BridgeMD
New treatment option for Pulmonary Infection
Official title Remimazolam for Bronchoscopy in High-Risk Patients
ClinicalTrials.gov ID: NCT07395596
What this study is testing
What is propofol and alfentanil?
propofol and alfentanil is an investigational medicine, being studied as a potential treatment for pulmonary infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Bronchoscopy is currently widely used for the diagnosis and treatment of various respiratory diseases. However, the operation of bronchoscopy is irritating, causes a strong stress response, and shares the airway with the patient, making the patient highly susceptible to respiratory and cardiovascular risks.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ASA Class Ⅲ - Ⅳ
- Scheduled for elective painless bronchoscopy -
You likely can't join if
- Age \< 18 years
- Patients who are uncooperative（e.g. due to mental illness）
- Patients who are on chronic use of opioids, benzodiazepine - class hypnotics, or antidepressants
- Patients with a history of allergy to the anesthetics used
- Patients who are anticipated to have a difficult airway
- Body mass index（BMI）\ 30kg/m²
See the full eligibility criteria
- ASA Class Ⅲ - Ⅳ
- Scheduled for elective painless bronchoscopy -
- Age \< 18 years
- Patients who are uncooperative（e.g. due to mental illness）
- Patients who are on chronic use of opioids, benzodiazepine - class hypnotics, or antidepressants
- Patients with a history of allergy to the anesthetics used
- Patients who are anticipated to have a difficult airway
- Body mass index（BMI）\ 30kg/m²
- Preoperative oxygen saturation \<92% while breathing room air
- Other：Patients who are deemed by the investigator to be unsuitable for participation in this trial
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
- Shaoxing, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China; Shaoxing, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.